51
|
Chintakuntlawar AV, Yin J, Foote RL, Kasperbauer JL, Rivera M, Asmus E, Garces NI, Janus JR, Liu M, Ma DJ, Moore EJ, Morris JC, Neben-Wittich M, Price DL, Price KA, Ryder M, Van Abel KM, Hilger C, Samb E, Bible KC. A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer. Thyroid 2019; 29:1615-1622. [PMID: 31595822 DOI: 10.1089/thy.2019.0086] [Citation(s) in RCA: 40] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Background: Anaplastic thyroid cancer (ATC) has poor prognosis with median overall survival (OS) of ∼6 months. We previously reported high PD-1/PDL-1 staining in ATC, raising the possibility of the productive application of the immunotherapeutic pembrolizumab. However, having found pembrolizumab to anecdotally have limited single-agent activity in ATC, we sought to alternatively define whether pembrolizumab might synergistically combine with chemoradiotherapy as initial ATC therapy. Methods: An investigator-initiated therapeutic phase 2 trial of pembrolizumab, 200 mg intravenously (IV) every 3 weeks, combined with chemoradiotherapy (docetaxel/doxorubicin, 20 mg/m2 each IV weekly plus volumetric modulated arc therapy) was initiated as frontline therapy (with or without surgery) in ATC to assess efficacy and toxicities. Six-month OS was selected as the primary endpoint using a Simon's optimal design with interim analysis (targeting accrual of 25 patients; Cohort A: prior resection, Cohort B: no resection). Based on a prior patient cohort-treated similarly, but without pembrolizumab, the design was such that, if 6-month true survival is 75%, the probability of declaring the approach worthy of further pursuit would be 91%. Results: Three patients were enrolled, two with rapidly enlarging unresectable neck masses. Early tumor responses were favorable in all three, and all three satisfactorily completed: intended radiotherapy, preceding and radiotherapy-concurrent pembrolizumab, and concurrent chemoradiotherapy. However, all three patients died <6 months following therapy initiation-one from pulmonary metastases and two from otherwise unexpected fatal pulmonary complications occurring subsequent to chemoradiotherapy completion-prompting study closure. Conclusions: Although initially tolerated and effective in terms of locoregional disease control, disappointing survival outcomes compared with historical controls raise uncertainty that the piloted approach merits further pursuit in ATC.
Collapse
Affiliation(s)
| | - Jun Yin
- Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota
| | - Robert L Foote
- Department of Radiation Oncology and Mayo Clinic, Rochester, Minnesota
| | - Jan L Kasperbauer
- Division of Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota
| | - Michael Rivera
- Department of Laboratory and Anatomical Pathology, Mayo Clinic, Rochester, Minnesota
| | - Erik Asmus
- Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota
| | - Nina I Garces
- Department of Radiation Oncology and Mayo Clinic, Rochester, Minnesota
| | - Jeffrey R Janus
- Division of Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota
| | - Minetta Liu
- Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota
| | - Daniel J Ma
- Department of Radiation Oncology and Mayo Clinic, Rochester, Minnesota
| | - Eric J Moore
- Division of Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota
| | - John C Morris
- Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota
- Division of Endocrinology, Mayo Clinic, Rochester, Minnesota
| | | | - Daniel L Price
- Division of Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota
| | | | - Mabel Ryder
- Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota
- Division of Endocrinology, Mayo Clinic, Rochester, Minnesota
| | | | - Crystal Hilger
- Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota
| | - Eleyna Samb
- Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota
| | - Keith C Bible
- Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota
| |
Collapse
|
52
|
Vicent Alaminos L, Cinca J, Vazquez-Garcia R, Gonzalez-Juanatey JR, Rivera M, Segovia JR, Pascual-Figal D, Bover R, Worner F, Delgado-Jimenez J, Fernandez-Aviles F, Martinez-Selles M. P4535Discharge treatment with ACE inhibitor/ARB after a heart failure hospitalization is associated with a better prognosis irrespectively of left ventricular ejection fraction. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0927] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Medical therapy could improve the prognosis of real-life patients discharged after a heart failure (HF) hospitalization.
Purpose
We aimed to determine the impact of discharge HF treatment on mortality and readmissions in different left ventricular ejection fraction (LVEF) groups.
Methods
Multicentre prospective registry in 20 Spanish hospitals. Patients were enrolled after a HF hospitalization.
Results
A total of 1831 patients were included (583 [31.8%] HF with reduced ejection fraction [HFrEF]; 227 [12.4%] HF with midrange ejection fraction [HFmrEF]; 610 [33.3%] HF with preserved ejection fraction [HFpEF], and 411 [22.4%] with unknown LVEF. Angiotensin-converting enzyme (ACE) inhibitors/Angiotensin II receptor blockers (ARB) at discharge were independently associated with a reduction in: i) all-cause mortality: hazard ratio (HR) 0.55, 95% confidence interval (CI) 0.41–0.74, P<0.001, with a similar effect in the four groups; ii) mortality due to refractory HF HR 0.45, 95% CI 0.29–0.64, P<0.001, with a similar effect in the three groups with known LVEF; iii) mortality/HF admissions (HR 0.61; 95% CI: 0.50–0.74), more evident in HFrEF (HR 0.54; 95% CI: 0.38–0.78) compared to HRmEF (HR 0.64; 95% CI 0.40–1.02), orHFpEF (HR 0.70; 95% CI 0.53–0.92).Inpatients with HFrEFtriple therapy (ACE inhibitor/ARB+ betablocker+ mineralocorticoid receptor antagonist) was associated with the lowest mortality risk (HR 0.21; 95% CI: 0.08–0.57, P=0.002) compared to patients that received none of these drugs.
Events according to the number of drugs – HFrEF (n=583) 0 (n=14) 1 (n=98) 2 (n=160) 3 (n=294) P Death or heart failure readmissions 10 (71.4) 58 (59.2) 66 (41.3) 106 (36.1) <0.001 All-cause mortality 9 (64.3) 28 (28.6) 31 (19.4) 36 (12.2) <0.001 Mortality due to refractory heart failure 7 (50.0) 14 (14.3) 17 (10.6) 17 (5.8) <0.001 – HFmrEF (n=227) 0 (n=18) 1 (n=57) 2 (n=81) 3 (n=65) P Death or heart failure readmissions 9 (50.0) 35 (61.4) 34 (42.0) 25 (38.5) 0.057 All-cause mortality 5 (27.8) 18 (31.6) 15 (18.5) 11 (16.9) 0.191 Mortality due to refractory heart failure 3 (16.7) 7 (12.3) 7 (8.6) 4 (6.2) 0.475 – HFpEF (n=610) 0 (n=61) 1 (n=242) 2 (n=219) 3 (n=69) P Death or heart failure readmissions 32 (52.5) 97 (40.1) 89 (40.6) 20 (29.0) 0.057 All-cause mortality 20 (32.8) 41 (16.9) 32 (14.6) 10 (14.5) 0.017 Mortality due to refractory heart failure 11 (18.0) 18 (7.4) 13 (5.9) 4 (5.8) 0.041 Outcomes according to the number of medications at discharge.
Kaplan-Meier Curves for study outcomes
Conclusions
Discharge treatment with ACE inhibitor/ARB after a HF hospitalization is associated with a reduction in all-cause and refractory HF mortality, irrespectively of LVEF.
Collapse
Affiliation(s)
| | - J Cinca
- Hospital Sant Pau, Barcelona, Spain
| | | | | | - M Rivera
- University Hospital Clinic of Valencia, Valencia, Spain
| | - J R Segovia
- University Hospital Puerta de Hierro Majadahonda, Madrid, Spain
| | | | - R Bover
- Hospital Clinic San Carlos, Madrid, Spain
| | - F Worner
- University Hospital Arnau de Vilanova, Valencia, Spain
| | | | | | | |
Collapse
|
53
|
Sauter JL, Lehrke H, Zhang X, Al Badri OT, Rodriguez-Gutierrez R, Delivanis DA, Singh Ospina N, Donegan D, Hamidi O, Iñiguez-Ariza N, Sharma A, Kittah NEN, Tamhane SU, Hurtado Andrade MD, Kotwal A, Jenkins SM, Spears G, Rivera M, Dean DS, Henry MR. Assessment of The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 2019; 152:502-511. [PMID: 31305880 DOI: 10.1093/ajcp/aqz076] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023] Open
Abstract
OBJECTIVES Long-term follow-up is important for determining performance characteristics of thyroid fine-needle aspiration (FNA). METHODS Histologic or 3 or more years of clinical follow-up was used to calculate performance characteristics of thyroid FNA before and after implementation of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) classification was also investigated. RESULTS Follow-up was obtained for 1,277/1,134 and 1,616/1,393 aspirates/patients (median clinical follow-up, 9.9 and 4.4 years, pre- and post-TBSRTC, respectively). Nondiagnostic, suspicious for follicular neoplasm, and suspicious for malignancy (SFM) diagnoses decreased and benign diagnoses increased post-TBSRTC, while atypical rate remained less than 1%. Negative predictive value for benign nodules and positive predictive value (PPV) for SFM increased significantly. Eleven nodules were reclassified as NIFTP, slightly decreasing PPV/risk of malignancy (ROM). CONCLUSIONS Appropriate ROM for thyroid FNA can be achieved through application of TBSRTC terminology with minimal use of atypical category.
Collapse
Affiliation(s)
- Jennifer L Sauter
- Division of Anatomic Pathology, Mayo Clinic, Rochester, MN
- Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Heidi Lehrke
- Division of Anatomic Pathology, Mayo Clinic, Rochester, MN
| | - Xiaotun Zhang
- Division of Anatomic Pathology, Mayo Clinic, Rochester, MN
| | | | - Rene Rodriguez-Gutierrez
- Division of Endocrinology, Mayo Clinic, Rochester, MN
- KER-Unit, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Medicine, Mayo Clinic, Rochester, MN
- Plataforma INVEST Medicina UANL-KER Unit Mayo Clinic (KER Unit Mexico)
- Endocrinology Division, Department of Internal Medicine, University Hospital “Dr. Jose E. Gonzalez,” Universidad Autonoma de Nuevo Leon, Monterrey, Mexico
| | | | - Naykky Singh Ospina
- Division of Endocrinology, Mayo Clinic, Rochester, MN
- Division of Endocrinology, University of Florida, Gainesville
| | - Diane Donegan
- Division of Endocrinology, Mayo Clinic, Rochester, MN
| | - Oksana Hamidi
- Division of Endocrinology, Mayo Clinic, Rochester, MN
- Division of Endocrinology and Metabolism, UT Southwestern Medical Center, Dallas, TX
| | - Nicole Iñiguez-Ariza
- Division of Endocrinology, Mayo Clinic, Rochester, MN
- Department of Endocrinology and Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
| | - Anu Sharma
- Division of Endocrinology, Mayo Clinic, Rochester, MN
| | | | | | | | - Anupam Kotwal
- Division of Endocrinology, Mayo Clinic, Rochester, MN
| | - Sarah M Jenkins
- Department of Health Sciences Research, Mayo Clinic, Rochester, MN
| | - Grant Spears
- Department of Health Sciences Research, Mayo Clinic, Rochester, MN
| | - Michael Rivera
- Division of Anatomic Pathology, Mayo Clinic, Rochester, MN
| | - Diana S Dean
- Division of Endocrinology, Mayo Clinic, Rochester, MN
| | | |
Collapse
|
54
|
Guastaldi F, Faquin W, Rivera M, Gootkind F, Hashemi S, August M, Iafrate A, Kaban L, Troulis M. Clear cell odontogenic carcinoma: a rare jaw tumor. a review of 107 cases. Int J Oral Maxillofac Surg 2019. [DOI: 10.1016/j.ijom.2019.03.284] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
55
|
Kumar P, Parmananda P, Verma DK, Singla T, de Nicolás I, Escalona J, Rivera M. Entrainment of aperiodic and periodic oscillations in the Mercury Beating Heart system using external periodic forcing. Chaos 2019; 29:053112. [PMID: 31154773 DOI: 10.1063/1.5083179] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/29/2018] [Accepted: 04/25/2019] [Indexed: 06/09/2023]
Abstract
We report experimental results indicating entrainment of aperiodic and periodic oscillatory dynamics in the Mercury Beating Heart (MBH) system under the influence of superimposed periodic forcing. Aperiodic oscillations in MBH were controlled to generate stable topological modes, namely, circle, ellipse, and triangle, evolving in a periodic fashion at different parameters of the forcing signal. These periodic dynamics show 1:1 entrainment for circular and elliptical modes, and additionally the controlled system exhibits 1:2 entrainment for elliptical and triangular modes at a different set of parameters. The external periodic forcing of the periodic MBH system reveals the existence of domains of entrainment (1:1, 1:2, 1:3, and 1:4) represented in the Arnold tongue structures. Moreover, Devil's staircase is obtained when the amplitude-frequency space of parameters of the applied signal is scanned.
Collapse
Affiliation(s)
- Pawan Kumar
- Department of Physics, Indian Institute of Technology Bombay, Powai, Mumbai 400 076, India
| | - P Parmananda
- Department of Physics, Indian Institute of Technology Bombay, Powai, Mumbai 400 076, India
| | - Dinesh Kumar Verma
- Centro de Investigación en Ciencias - (IICBA), UAEM, Avenida Universidad 1001, Colonia Chamilpa, Cuernavaca, 62209 Morelos, Mexico
| | - Tanu Singla
- Centro de Investigación en Ciencias - (IICBA), UAEM, Avenida Universidad 1001, Colonia Chamilpa, Cuernavaca, 62209 Morelos, Mexico
| | - Iram de Nicolás
- Centro de Investigación en Ciencias - (IICBA), UAEM, Avenida Universidad 1001, Colonia Chamilpa, Cuernavaca, 62209 Morelos, Mexico
| | - J Escalona
- Centro de Investigación en Ciencias - (IICBA), UAEM, Avenida Universidad 1001, Colonia Chamilpa, Cuernavaca, 62209 Morelos, Mexico
| | - M Rivera
- Centro de Investigación en Ciencias - (IICBA), UAEM, Avenida Universidad 1001, Colonia Chamilpa, Cuernavaca, 62209 Morelos, Mexico
| |
Collapse
|
56
|
Ezzitouny M, Sánchez-Lázaro I, Rivera M, Portolés-Sanz M, Roselló-Lletí E, Gil-Cayuela C, Almenar-Bonet L, López-Vilella R, Ferré-Vallverdú M, Sanz-Sánchez J, Cerveró-Rubio A, Jiménez-Aguilella JJ, Pérez-Roselló V, Donoso-Trenado V, Arenas-Martín P, Lozano-Edo S, Jover-Pastor P, Martínez-Dolz L. Molecular Alterations of Nucleocytoplasmic Transport in Patients on the Heart Transplantation Waiting List and Its Correlation With the Severity and Etiology of Heart Failure. Transplant Proc 2019; 51:369-371. [PMID: 30879543 DOI: 10.1016/j.transproceed.2018.12.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2018] [Revised: 11/26/2018] [Accepted: 12/09/2018] [Indexed: 11/19/2022]
Abstract
OBJECTIVES To evaluate whether the levels of some molecules implicated in nucleocytoplasmic transport in human cardiomyocytes are related to the severity of heart failure (HF) in patients on the heart transplantation (HT) waiting list, and to determine whether there is a differential pattern of molecular alteration between ischemic cardiomyopathy (ICM) and non-ischemic dilated cardiomyopathy (DCM). METHODS Sixty-three blood samples collected before HT were analyzed to identify the levels of IMPORTIN5 (IMP5); IMPORTINalpha2; ATPaseCaTransp (ATPCa); NUCLEOPORIN153kDa (Nup153); NUCLEOPORIN160kDa (Nup160); RANGTPaseAP1 (RanGAP1) and EXPORTIN4 (EXP4). These data were then compared between patients with advanced HF with or without the need for ventricular support with extracorporeal membrane oxygenation (ECMO) as a bridge for HT, as well as between patients with non-ischemic DCM and patients with ICM. RESULTS Thirty-three patients had ICM, 26 had non-ischemic DCM, and 4 had heart disease. Seventeen patients required ventricular assistance as a bridge to HT. The levels of ATPCa, RanGAP1, and IMP5 were significantly higher in patients with ECMO, while EXP4 was significantly higher in patients without ECMO. Patients with DCM showed higher levels of IMP5, RanGAP1, and Nup153 than those with ICM. CONCLUSION Patients with advanced HF in critical condition (with ECMO as a bridge for HT) presented with significantly higher levels of ATPCa, RanGAP1, and IMP5, while patients with DCM had significantly higher levels of RanGAP1, IMP5, and Nup153. It remains to be clarified whether the determination of these molecules would facilitate the early identification of this group or if their alteration occurs as consequence of circulatory support with ECMO.
Collapse
Affiliation(s)
- M Ezzitouny
- Cardiology Service, La Fe University and Polytechnic Hospital, Valencia, Spain.
| | - I Sánchez-Lázaro
- Heart Failure and Transplant Unit, La Fe University and Polytechnic Hospital, Valencia, Spain
| | - M Rivera
- Health Research Institute La Fe, Valencia, Spain
| | | | | | | | - L Almenar-Bonet
- Heart Failure and Transplant Unit, La Fe University and Polytechnic Hospital, Valencia, Spain
| | - R López-Vilella
- Heart Failure and Transplant Unit, La Fe University and Polytechnic Hospital, Valencia, Spain
| | - M Ferré-Vallverdú
- Cardiology Service, La Fe University and Polytechnic Hospital, Valencia, Spain
| | - J Sanz-Sánchez
- Cardiology Service, La Fe University and Polytechnic Hospital, Valencia, Spain
| | - A Cerveró-Rubio
- Cardiology Service, La Fe University and Polytechnic Hospital, Valencia, Spain
| | | | - V Pérez-Roselló
- Cardiology Service, La Fe University and Polytechnic Hospital, Valencia, Spain
| | - V Donoso-Trenado
- Cardiology Service, La Fe University and Polytechnic Hospital, Valencia, Spain
| | - P Arenas-Martín
- Cardiology Service, La Fe University and Polytechnic Hospital, Valencia, Spain
| | - S Lozano-Edo
- Cardiology Service, La Fe University and Polytechnic Hospital, Valencia, Spain
| | - P Jover-Pastor
- Cardiology Service, La Fe University and Polytechnic Hospital, Valencia, Spain
| | - L Martínez-Dolz
- Heart Failure and Transplant Unit, La Fe University and Polytechnic Hospital, Valencia, Spain
| |
Collapse
|
57
|
Gupta N, Rivera M, Novotny P, Rodriguez V, Bancos I, Lteif A. Adrenocortical Carcinoma in Children: A Clinicopathological Analysis of 41 Patients at the Mayo Clinic from 1950 to 2017. Horm Res Paediatr 2018; 90:8-18. [PMID: 29804118 DOI: 10.1159/000488855] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/21/2017] [Accepted: 03/26/2018] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND/AIMS Adrenocortical carcinoma (ACC) is an aggressive childhood cancer. Limited evidence exists on a definite histopathological criterion to differentiate ACC from adrenocortical adenoma. The aim of this study was to investigate the clinicopathological data of children with ACC, identify prognostic factors, and validate a histopathological criterion to differentiate ACC from adrenocortical adenoma. METHODS This retrospective cohort included 41 children, followed at the Mayo Clinic from 1950 to 2017 (onset of symptoms ≤21 years). Outcomes of interest were: alive with no evidence of disease, alive with evidence of disease, and dead of disease. RESULTS Median age at onset of symptoms was 15.7 years (n = 41; range, 0.2-21 years). Female:male ratio was 3.6: 1. Mixed symptomatology (> 1 hormone abnormality) was the most common presentation (54%, n = 22). Sixty-six percent of patients (n = 27 out of 41) underwent total adrenalectomy. Metastatic disease was more common in children aged > 12 years (p = 0.002 compared to < 4 years). The most common sites of metastases were the liver and lungs. Overall 2-year and 5-year survival rates were 61% (95% CI 45-77) and 46% (95% CI 30-62), respectively. Metastasis at the time of diagnosis was independently associated with poor prognosis (risk ratio 13.7%; 95% CI 3.9-87.7). Weiss criteria (29%) and modified Weiss criteria (33%) were less accurate in younger patients (< 12 years), compared to the Wieneke index (100%). CONCLUSION The presence of metastases was an independent prognostic factor. The Wieneke index was the most accurate in predicting clinical outcomes in younger children.
Collapse
Affiliation(s)
- Nidhi Gupta
- Division of Pediatric Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota, USA
| | - Michael Rivera
- Department of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota, USA
| | - Paul Novotny
- Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA
| | - Vilmarie Rodriguez
- Division of Pediatric Hematology-Oncology, Mayo Clinic, Rochester, Minnesota, USA
| | - Irina Bancos
- Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA
| | - Aida Lteif
- Division of Pediatric Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota, USA
| |
Collapse
|
58
|
Miller KC, Marinelli JP, Van Gompel JJ, Link MJ, Janus JR, Foote RL, Price KA, Garcia J, Rivera M, Chintakuntlawar AV. Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma. Head Neck 2018; 41:1335-1341. [PMID: 30536472 DOI: 10.1002/hed.25558] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2018] [Revised: 08/28/2018] [Accepted: 11/15/2018] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND Past research established that surgery plus adjuvant radiotherapy (S + AR) improves overall survival (OS) in esthesioneuroblastoma (ENB). However, it is unknown if the addition of adjuvant chemotherapy (AC) further improves survival. The primary objective of this study was to compare survival among patients treated with S + AR alone to patients who underwent S + AR + AC. METHODS Retrospective review of patient records. RESULTS Thirty-eight patients met inclusion criteria for either S + AR or S + AR + AC treatment groups. The S + AR + AC group contained more patients with Kadish stage D disease, dural invasion, and positive histologic margins postsurgery. All S + AR + AC patients received platinum-based regimens, combined with etoposide in 67%. OS and recurrence-free survival did not differ between the two groups, even when restricting the analysis to patients with Kadish stages B and C disease. CONCLUSION Patients who received platinum-based AC did not exhibit improved survival compared to S + AR alone. Further investigation, preferably prospective, into the optimal use of systemic therapy in ENB is warranted.
Collapse
Affiliation(s)
- Kevin C Miller
- Mayo Clinic School of Medicine, Mayo Clinic, Rochester, Minnesota
| | - John P Marinelli
- Mayo Clinic School of Medicine, Mayo Clinic, Rochester, Minnesota
| | - Jamie J Van Gompel
- Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota.,Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota
| | - Michael J Link
- Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota.,Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota
| | - Jeffrey R Janus
- Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota
| | - Robert L Foote
- Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota
| | | | - Joaquin Garcia
- Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, Minnesota
| | - Michael Rivera
- Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, Minnesota
| | | |
Collapse
|
59
|
|
60
|
Rivera M, Ha B, Zamini L, Gamby S, Pitter D, Muhoro CN. N-methylcarbamate pesticides and their phenolic degradation products: hydrolytic decay, sequestration and metal complexation studies. J Environ Sci Health B 2018; 54:54-60. [PMID: 30460875 DOI: 10.1080/03601234.2018.1531659] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2018] [Revised: 09/25/2018] [Accepted: 09/27/2018] [Indexed: 06/09/2023]
Abstract
We report on the rates of decomposition of a group of N-methylcarbamate (NMC) pesticides (carbaryl, carbofuran and propoxur) under pre-determined tropical field conditions. Rates of decomposition for three NMCs were determined at pH 7.08 and T = 20 °C and pH 7.70 and T = 33 °C respectively, as follows: carbaryl (78 days and 69 days); carbofuran (143 days and 83 days) and propoxur (116 days and 79 days). Investigation on methods for removal of NMCs and their phenolic decomposition products shows that activated charcoal outperforms zeolite, alumina, diatomaceous earth, cellulose and montmorillonite clay in the removal of both NMCs and phenols from aqueous solution. Furthermore, metal complexation studies on the NMCs and phenols showed that Fe (III) forms a complex with isopropoxyphenol (IPP) within which the Fe:IPP ratio is 1:3, indicative of the formation of a metal chelate complex with the formula Fe(IPP)3.
Collapse
Affiliation(s)
- Michael Rivera
- a Department of Chemistry , Towson University, Jess and Mildred Fisher College of Science and Mathematics , Towson , Maryland , USA
| | - Bao Ha
- a Department of Chemistry , Towson University, Jess and Mildred Fisher College of Science and Mathematics , Towson , Maryland , USA
| | - Leili Zamini
- a Department of Chemistry , Towson University, Jess and Mildred Fisher College of Science and Mathematics , Towson , Maryland , USA
| | - Sonja Gamby
- a Department of Chemistry , Towson University, Jess and Mildred Fisher College of Science and Mathematics , Towson , Maryland , USA
| | - Demar Pitter
- a Department of Chemistry , Towson University, Jess and Mildred Fisher College of Science and Mathematics , Towson , Maryland , USA
| | - Clare N Muhoro
- a Department of Chemistry , Towson University, Jess and Mildred Fisher College of Science and Mathematics , Towson , Maryland , USA
| |
Collapse
|
61
|
De Battisti E, Buja A, Rivera M, Corti MC, Avossa F, Schievano E, Rigon S, Baldo V, Boccuzzo G, Ebell MH. Multimorbidity and health outcomes in high-need, high-cost elderly patients. Eur J Public Health 2018. [DOI: 10.1093/eurpub/cky214.241] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
| | - A Buja
- University of Padua, Padua, Italy
| | - M Rivera
- University of Padua, Padua, Italy
| | - MC Corti
- Veneto Regional Authority, Venice, Italy
| | - F Avossa
- Veneto Regional Authority, Venice, Italy
| | | | - S Rigon
- Veneto Regional Authority, Venice, Italy
| | - V Baldo
- University of Padua, Padua, Italy
| | | | - MH Ebell
- University of Georgia, Athens, USA
| |
Collapse
|
62
|
Aragón-Herrera A, Feijóo-Bandín S, Rodríguez-Penas D, Roselló-Lletí E, Portolés M, Rivera M, Bigazzi M, Bani D, Gualillo O, González-Juanatey JR, Lago F. Relaxin activates AMPK-AKT signaling and increases glucose uptake by cultured cardiomyocytes. Endocrine 2018; 60:103-111. [PMID: 29411306 DOI: 10.1007/s12020-018-1534-3] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/10/2017] [Accepted: 01/15/2018] [Indexed: 12/22/2022]
Abstract
PURPOSE Many evidences show that the hormone relaxin plays a pivotal role in the physiology and pathology of the cardiovascular system. This pleiotropic hormone exerts regulatory functions through specific receptors in cardiovascular tissues: in experimental animal models it was shown to induce coronary vasodilation, prevent cardiac damage induced by ischemia/reperfusion and revert cardiac hypertrophy and fibrosis. A tight relationship between this hormone and important metabolic pathways has been suggested, but it is at present unknown if relaxin could regulate cardiac metabolism. Our aim was to study the possible effects of relaxin on cardiomyocyte metabolism. METHODS Neonatal rat cardiomyocytes were treated with relaxin and (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assays (MTT) were performed to assess metabolic activity; while 2-deoxy-D-[3H] glucose and BODIPY-labelled fatty acid incorporations were analyzed to measure glucose and fatty acid uptakes, and western blot was utilized to study the intracellular signaling pathways activated by the hormone. RESULTS We observed that relaxin at 10 ng/ml was able to increase the level of metabolic activity of cultured neonatal rat cardiomyocytes; the rate of 2-deoxy-D-[3H]glucose incorporation demonstrated that relaxin also induced an increase in glucose uptake. First evidence is also offered that relaxin can activate the master energy sensor and regulator AMPK in cardiomyocytes. Moreover, the treatment of cardiomyocytes with relaxin also induced dose-dependent increases in ERK1/2, AKT, and AS160 phosphorylation. That raise in AS160 phosphorylation induced by relaxin was prevented by the pretreatment with AMPK and AKT pathways inhibitors, indicating that both molecules play important roles in the relaxin effects reported. CONCLUSION Relaxin can regulate cardiomyocyte metabolism and activate AMPK, the central sensor of energy status that maintains cellular energy homeostasis, and also ERK and AKT, two molecular sensing nodes that coordinate dynamic responses of the cell's metabolic responses.
Collapse
Affiliation(s)
- A Aragón-Herrera
- Cellular and Molecular Cardiology Unit and Department of Cardiology, Institute of Biomedical Research (IDIS-SERGAS), Santiago de Compostela, Spain
| | - S Feijóo-Bandín
- Cellular and Molecular Cardiology Unit and Department of Cardiology, Institute of Biomedical Research (IDIS-SERGAS), Santiago de Compostela, Spain.
- CIBERCV, Institute of Health Carlos III, Madrid, Spain.
| | - D Rodríguez-Penas
- Cellular and Molecular Cardiology Unit and Department of Cardiology, Institute of Biomedical Research (IDIS-SERGAS), Santiago de Compostela, Spain
| | - E Roselló-Lletí
- CIBERCV, Institute of Health Carlos III, Madrid, Spain
- Cardiocirculatory Unit, Health Institute of La Fe University Hospital (IIS La Fe), Valencia, Spain
| | - M Portolés
- CIBERCV, Institute of Health Carlos III, Madrid, Spain
- Cardiocirculatory Unit, Health Institute of La Fe University Hospital (IIS La Fe), Valencia, Spain
| | - M Rivera
- CIBERCV, Institute of Health Carlos III, Madrid, Spain
- Cardiocirculatory Unit, Health Institute of La Fe University Hospital (IIS La Fe), Valencia, Spain
| | - M Bigazzi
- Prosperius Institute, Florence, Italy
| | - D Bani
- Prosperius Institute, Florence, Italy
| | - O Gualillo
- Neuroendocrine Interaccions in Rheumatology and Inflammatory Diseases Unit, Institute of Biomedical Research (IDIS-SERGAS), Santiago de Compostela, Spain
| | - J R González-Juanatey
- Cellular and Molecular Cardiology Unit and Department of Cardiology, Institute of Biomedical Research (IDIS-SERGAS), Santiago de Compostela, Spain
- CIBERCV, Institute of Health Carlos III, Madrid, Spain
| | - F Lago
- Cellular and Molecular Cardiology Unit and Department of Cardiology, Institute of Biomedical Research (IDIS-SERGAS), Santiago de Compostela, Spain
- CIBERCV, Institute of Health Carlos III, Madrid, Spain
| |
Collapse
|
63
|
Affiliation(s)
- Lori A Erickson
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
| | - Michael Rivera
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
| |
Collapse
|
64
|
Ghosh T, VandeHaar MA, Rivera M, Henry MR. High-risk HPV genotype distribution in HPV co-test specimens: study of a predominantly Midwestern population. J Am Soc Cytopathol 2018; 7:99-105. [PMID: 31043259 DOI: 10.1016/j.jasc.2017.09.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2017] [Revised: 09/19/2017] [Accepted: 09/27/2017] [Indexed: 10/18/2022]
Abstract
INTRODUCTION High-risk HPV (HR-HPV) genoprevalence was assessed in cytologic specimens co-tested for HR-HPV in a predominantly Midwestern U.S. population, of which there are limited current data. These baseline data will aid in determining future shifts in HR-HPV genoprevalence. METHODS A total of 40,739 cervical/endocervical samples collected in PreservCyt (ThinPrep) media at Mayo Clinic, Rochester, MN, underwent HR-HPV co-testing between January 2014 and December 2016 in women aged 30-98 years. This included 37,656 negative for intraepithelial lesion (NIL), 1696 atypical squamous cells of undetermined significance (ASC-US), 159 atypical squamous cells, cannot exclude HSIL (ASC-H), 911 low-grade squamous intraepithelial lesion (LSIL), 188 high-grade intraepithelial lesion (HSIL), and 129 atypical glandular cells of undetermined significance (AGUS) cases. Roche cobas 4800 classified HR-HPV genotypes as 16, 18, or "other" (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68). RESULTS Of 40,739 co-tested specimens, 3786 were positive for at least one HR-HPV strain. "Other" only genotypes were most prevalent (74.3% of all HR-HPV cases). HPV16 and/or HPV18 were more common in the more significant diagnoses and were present in 59.1% of HSIL. HPV16-only was second most prevalent, with highest prevalence in HSIL (33.3%) and ASC-H (20.6%). HPV16 combined with "other" was third most prevalent, except in AGUS. HR-HPV (all genotypes) was most prevalent in those aged 30-39 years, decreasing with age (P < 0.0001). There was a trend toward HPV16 prevalence increasing with age (P = 0.4244). CONCLUSIONS HR-HPV "other" combination was most prevalent in all diagnoses except HSIL, in which HPV16 and/or HPV18 (exclusive of "other" genotypes) were most prevalent.
Collapse
Affiliation(s)
- Toshi Ghosh
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
| | - Mark A VandeHaar
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
| | - Michael Rivera
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
| | - Michael R Henry
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
| |
Collapse
|
65
|
Prasongsook N, Kumar A, Chintakuntlawar AV, Foote RL, Kasperbauer J, Molina J, Garces Y, Ma D, Wittich MAN, Rubin J, Richardson R, Morris J, Hay I, Fatourechi V, McIver B, Ryder M, Thompson G, Grant C, Richards M, Sebo TJ, Rivera M, Suman V, Jenkins SM, Smallridge RC, Bible KC. Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer. J Clin Endocrinol Metab 2017; 102:4506-4514. [PMID: 29029287 DOI: 10.1210/jc.2017-01180] [Citation(s) in RCA: 69] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/23/2017] [Accepted: 09/27/2017] [Indexed: 12/11/2022]
Abstract
CONTEXT Historical outcomes in anaplastic thyroid cancer (ATC) have been dismal. OBJECTIVE To determine whether an initial intensive multimodal therapy (MMT) is associated with improved ATC survival. DESIGN MMT was offered to all patients with newly diagnosed ATC treated at the Mayo Clinic from 2003 through 2015; MMT vs care with palliative intent (PI) was individualized considering clinical status and patient preferences. Outcomes were retrospectively analyzed by American Joint Committee on Cancer stage and treatments compared with patient cohort data from 1949 through 1999. PATIENTS Forty-eight patients (60% male; median age, 62 years); 18 treated with PI, 30 with MMT. MAIN OUTCOME MEASURE Overall survival (OS) and progression-free survival determined by Kaplan-Meier method. RESULTS Median OS and 1-year survival for the later cohort were 9 months [95% confidence interval (CI), 4 to 22 months] and 42% (95% CI, 28% to 56%) vs 3 months and 10% for the earlier cohort. Median OS was 21 months compared with 3.9 months in the pooled MMT vs PI groups for the later cohort [hazard ratio (HR), 0.32; P = 0.0006]. Among only patients in the later cohort who had stage IVB disease, median OS was 22.4 vs 4 months (HR, 0.12; 95% CI, 0.03 to 0.44; P = 0.0001), with 68% vs 0% alive at 1 year (MMT vs PI). Among patients with stage IVC cancer, OS did not differ by therapy. CONCLUSION MMT appears to convey longer survival in ATC among patients with stage IVA/B disease.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - Daniel Ma
- Department of Radiation Oncology, Mayo Clinic
| | | | | | | | | | - Ian Hay
- Division of Endocrinology, Mayo Clinic
| | | | | | - Mabel Ryder
- Division of Medical Oncology, Mayo Clinic
- Division of Endocrinology, Mayo Clinic
| | | | | | | | - Thomas J Sebo
- Department of Laboratory and Anatomical Pathology, Mayo Clinic
| | - Michael Rivera
- Department of Laboratory and Anatomical Pathology, Mayo Clinic
| | - Vera Suman
- Division of Biomedical Statistics and Informatics, Mayo Clinic
| | - Sarah M Jenkins
- Division of Biomedical Statistics and Informatics, Mayo Clinic
| | - Robert C Smallridge
- Division of Endocrinology, Mayo Clinic
- Endocrine Malignancies Disease Oriented Group, Mayo Clinic Cancer Center
| | | |
Collapse
|
66
|
Alvarez-Garcia J, Garcia-Osuna A, Ferrero-Gregori A, Vives-Borras M, Perez-Calleja R, Puig T, Rivera M, Pascual-Figal D, Alonso-Pulpon L, Fernandez-Aviles F, Delgado J, Gonzalez-Juanatey J, Worner F, Ordonez-Llanos J, Cinca J. P5287Time course of a set of biomarkers during compensation of an acute heart failure episode. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.p5287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- J. Alvarez-Garcia
- Hospital de la Santa Creu i Sant Pau, IIb-Sant Pau, CIBERCV, Universitat A, Cardiology, Barcelona, Spain
| | - A. Garcia-Osuna
- Hospital de la Santa Creu i Sant Pau, Biochemistry, Barcelona, Spain
| | - A. Ferrero-Gregori
- Hospital de la Santa Creu i Sant Pau, IIb-Sant Pau, CIBERCV, Universitat A, Cardiology, Barcelona, Spain
| | - M. Vives-Borras
- Hospital de la Santa Creu i Sant Pau, IIb-Sant Pau, CIBERCV, Universitat A, Cardiology, Barcelona, Spain
| | - R. Perez-Calleja
- Hospital de la Santa Creu i Sant Pau, Biochemistry, Barcelona, Spain
| | - T. Puig
- Hospital de la Santa Creu i Sant Pau, IIb-Sant Pau, CIBERCV, Universitat A, Cardiology, Barcelona, Spain
| | - M. Rivera
- University Hospital La Fe, Cardiology, Valencia, Spain
| | - D. Pascual-Figal
- Hospital Clínico Univeristario Virgen de la Arrixaca, Cardiology, Murcia, Spain
| | - L. Alonso-Pulpon
- University Hospital Puerta de Hierro Majadahonda, Cardiology, Madrid, Spain
| | | | - J. Delgado
- University Hospital 12 de Octubre, Cardiology, Madrid, Spain
| | - J.R. Gonzalez-Juanatey
- University Hospital of Santiago de Compostela, Cardiology, Santiago de Compostela, Spain
| | - F. Worner
- Hospital Arnau de Vilanova, Cardiology, Lleida, Spain
| | - J. Ordonez-Llanos
- Hospital de la Santa Creu i Sant Pau, Biochemistry, Barcelona, Spain
| | - J. Cinca
- Hospital de la Santa Creu i Sant Pau, IIb-Sant Pau, CIBERCV, Universitat A, Cardiology, Barcelona, Spain
| | | |
Collapse
|
67
|
Aragon Herrera A, Feijoo-Bandin S, Rodriguez-Penas D, Rosello-Lleti E, Portoles M, Rivera M, Gonzalez-Ferreiro R, Varela-Roman A, Gonzalez-Juanatey J, Lago F. P6198Plasma levels of the proinflammatory adipocytokine chemerin correlate with lean/fat mass index in patients with heart failure. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.p6198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
68
|
Henderson L, Jones L, Benefield T, Reuland D, Brenner A, Molina P, Rivera M. P1.03-038 Appropriateness of Lung Cancer Screening with Low Dose Computed Tomography. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2016.11.709] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
69
|
Rivera M, Hoffmann J, Wulf-Goldenberg A, Schlag P, Merk J, Walther W, Fichtner I. Evaluation of potential predictive biomarker for cetuximab in a panel of colorectal cancer patient-derived xenografts (PDX). Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)32749-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
70
|
Aguirre JI, Akhter MP, Neuville KG, Trcalek CR, Leeper AM, Williams AA, Rivera M, Kesavalu L, Ke HZ, Liu M, Kimmel DB. Age-related periodontitis and alveolar bone loss in rice rats. Arch Oral Biol 2016; 73:193-205. [PMID: 27771588 DOI: 10.1016/j.archoralbio.2016.10.018] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2015] [Revised: 08/18/2016] [Accepted: 10/15/2016] [Indexed: 12/20/2022]
Abstract
OBJECTIVE To characterize in rice rats: (a) periodontitis (PD) progress with feeding of standard laboratory rat chow (STD) during ages 4-80 weeks; and (b) PD progress with feeding of a high sucrose-casein (H-SC) diet during young adulthood. METHODS One group (N=12) was euthanized at age 4 weeks (Baseline). Four groups (N=8-16) consumed a STD diet from baseline and were necropsied at ages 22, 30, 52, and 80 weeks. Three groups (N=10-16) consumed an H-SC diet from baseline. Two were necropsied at ages 22 and 30 weeks, respectively. The third switched to the STD diet at age 22 weeks and was necropsied at age 30 weeks. All mandibles/maxillae were assessed by histometry for degree of periodontal inflammation (PD Score), alveolar crest height (ACH, mm), and horizontal alveolar bone height (hABH, mm2). RESULTS In STD diet rats aged ≥30 weeks, all endpoints were worse (P<0.05) than at Baseline. In H-SC diet rats aged ≥22 weeks, all endpoints were worse than at Baseline (P<0.05). At age 22 weeks, all endpoints were worse in the H-SC group than in the STD group (P<0.05). By age 30 weeks, the STD and H-SC groups did not differ. CONCLUSIONS 1) STD diet fed rice rats develop moderate/severe PD by age 30 weeks; 2) an H-SC diet accelerates moderate/severe PD development; and 3) switching to a STD diet does not halt/reverse PD that was accelerated by an H-SC diet. These data further clarify use of the rice rat as a PD model.
Collapse
Affiliation(s)
- J I Aguirre
- Department of Physiological Sciences, College of Veterinary Medicine, University of Florida (UF), Gainesville, FL 32610, United States.
| | - M P Akhter
- Osteoporosis Research Center, School of Medicine, Creighton University, Omaha, NE 68131, United States.
| | - K G Neuville
- Department of Physiological Sciences, College of Veterinary Medicine, University of Florida (UF), Gainesville, FL 32610, United States.
| | - C R Trcalek
- Department of Physiological Sciences, College of Veterinary Medicine, University of Florida (UF), Gainesville, FL 32610, United States.
| | - A M Leeper
- Department of Physiological Sciences, College of Veterinary Medicine, University of Florida (UF), Gainesville, FL 32610, United States.
| | - A A Williams
- Department of Physiological Sciences, College of Veterinary Medicine, University of Florida (UF), Gainesville, FL 32610, United States.
| | - M Rivera
- Department of Periodontology and Oral Biology, College of Dentistry, UF, United States.
| | - L Kesavalu
- Department of Periodontology and Oral Biology, College of Dentistry, UF, United States; Bone Research, Amgen Inc., Thousand Oaks, CA 91320, United States.
| | - H Z Ke
- Bone Research, Amgen Inc., Thousand Oaks, CA 91320, United States.
| | - M Liu
- Bone Research, Amgen Inc., Thousand Oaks, CA 91320, United States.
| | - D B Kimmel
- Department of Physiological Sciences, College of Veterinary Medicine, University of Florida (UF), Gainesville, FL 32610, United States.
| |
Collapse
|
71
|
Bevilacqua J, Gonzalez-Quereda L, Castiglioni C, Zamorano I, Acevedo L, Díaz J, Rodríguez M, Trangulao A, Rivera M, Gallano P. Desminopathy in Chile, first cases reported. Neuromuscul Disord 2016. [DOI: 10.1016/j.nmd.2016.06.106] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
72
|
Fritchie KJ, Jin L, Wang X, Graham RP, Torbenson MS, Lewis JE, Rivera M, Garcia JJ, Schembri-Wismayer DJ, Westendorf JJ, Chou MM, Dong J, Oliveira AM. Fusion gene profile of biphenotypic sinonasal sarcoma: an analysis of 44 cases. Histopathology 2016; 69:930-936. [DOI: 10.1111/his.13045] [Citation(s) in RCA: 52] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2016] [Accepted: 07/21/2016] [Indexed: 02/04/2023]
Affiliation(s)
- Karen J Fritchie
- Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN USA
| | - Long Jin
- Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN USA
| | - Xiaoke Wang
- Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN USA
| | - Rondell P Graham
- Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN USA
| | - Michael S Torbenson
- Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN USA
| | - Jean E Lewis
- Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN USA
| | - Michael Rivera
- Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN USA
| | - Joaquin J Garcia
- Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN USA
| | | | | | - Margaret M Chou
- Department of Pathology and Laboratory Medicine; University of Pennsylvania; Philadelphia PA USA
| | - Jie Dong
- Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN USA
| | - Andre M Oliveira
- Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN USA
| |
Collapse
|
73
|
Abstract
Paragangliomas of the urinary bladder can arise sporadically or as a part of hereditary syndromes including those with underlying mutations in the succinate dehydrogenase (SDH) genes, which serve as tumor suppressors. SDH deficiency can be screened for by absence of immunohistochemical detection of SDHB. In this study of 11 cases, clinical follow-up was available for 9/11 cases. The cases were reviewed and graded based on the grading system for adrenal pheochromocytomas and paragangliomas (GAPP) criteria. Immunohistochemistry was performed for Ki67 and SDHB. Proliferative index was calculated by quantification of Ki67-positive cells at hot spots. The medical record was accessed for documentation of germline SDH mutations. Urinary bladder paragangliomas had a female predilection (8/11 cases), and 5/11 cases exhibited metastatic behavior. Patients with metastatic disease tended to be younger (mean age 43 vs 49 years), have larger lesions (5.8 vs 1.5 cm), and presented with catecholamine excess (4/4 vs 2/6 patients with non-metastatic lesions). Patients with metastatic disease had a higher mean Ki67 proliferation rate (4.9 vs 1.3 %) and GAPP score (mean of 5.8 vs 3.8) (p = 0.01). IHC for SDHB expression revealed loss of expression in 2/6 cases of non-metastatic paragangliomas compared to 4/5 patients with metastatic paragangliomas. Interestingly, of these four patients, two had a documented mutation of SDHB, one patient had a SDHC mutation, and another patient had a history of familial disease without mutation analysis being performed. Our study, suggests that SDH loss was suggestive of metastatic behavior in addition to younger age at diagnosis, larger tumor size, and higher Ki67 proliferation rate and catecholamine type.
Collapse
Affiliation(s)
- Sounak Gupta
- Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA
| | - Jun Zhang
- Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA
| | - Michael Rivera
- Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA
| | - Lori A Erickson
- Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
| |
Collapse
|
74
|
Agboola F, Herring R, Ghamsary M, Handysides D, Gleason P, Rivera M, Gutierrez S. Towards improving healthy food access through
community-supported-agriculture-farmshare programs in food desert areas and
among low income populations. Ann Glob Health 2016. [DOI: 10.1016/j.aogh.2016.04.117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
75
|
Tiwari I, Phogat R, Parmananda P, Ocampo-Espindola JL, Rivera M. Intrinsic periodic and aperiodic stochastic resonance in an electrochemical cell. Phys Rev E 2016; 94:022210. [PMID: 27627301 DOI: 10.1103/physreve.94.022210] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2016] [Indexed: 11/07/2022]
Abstract
In this paper we show the interaction of a composite of a periodic or aperiodic signal and intrinsic electrochemical noise with the nonlinear dynamics of an electrochemical cell configured to study the corrosion of iron in an acidic media. The anodic voltage setpoint (V_{0}) in the cell is chosen such that the anodic current (I) exhibits excitable fixed point behavior in the absence of noise. The subthreshold periodic (aperiodic) signal consists of a train of rectangular pulses with a fixed amplitude and width, separated by regular (irregular) time intervals. The irregular time intervals chosen are of deterministic and stochastic origins. The amplitude of the intrinsic internal noise, regulated by the concentration of chloride ions, is then monotonically increased, and the provoked dynamics are analyzed. The signal to noise ratio and the cross-correlation coefficient versus the chloride ions' concentration curves have a unimodal shape indicating the emergence of an intrinsic periodic or aperiodic stochastic resonance. The abscissa for the maxima of these unimodal curves correspond to the optimum value of intrinsic noise where maximum regularity of the invoked dynamics is observed. In the particular case of the intrinsic periodic stochastic resonance, the scanning electron microscope images for the electrode metal surfaces are shown for certain values of chloride ions' concentrations. These images, qualitatively, corroborate the emergence of order as a result of the interaction between the nonlinear dynamics and the composite signal.
Collapse
Affiliation(s)
- Ishant Tiwari
- Department of Physics, Indian Institute of Technology, Bombay, Powai, Mumbai-400 076, India
| | - Richa Phogat
- Department of Physics, Indian Institute of Technology, Bombay, Powai, Mumbai-400 076, India
| | - P Parmananda
- Department of Physics, Indian Institute of Technology, Bombay, Powai, Mumbai-400 076, India
| | - J L Ocampo-Espindola
- Centro de Investigación en Ciencias-(IICBA), UAEM, Avenida Universidad 1001, 62209 Cuernavaca, Morelos, México
| | - M Rivera
- Centro de Investigación en Ciencias-(IICBA), UAEM, Avenida Universidad 1001, 62209 Cuernavaca, Morelos, México
| |
Collapse
|
76
|
Rivera M, Merlin S, Hoda RS, Gopalan A, Hoda SA. Minimal Involvement of Sentinel Lymph Node in Breast Carcinoma: Prevailing Concepts and Challenging Problems. Int J Surg Pathol 2016; 12:301-6. [PMID: 15494855 DOI: 10.1177/106689690401200402] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Sentinel lymph node biopsy has attained “standard of care” status in the management of breast carcinoma. However, the pathological interpretation and clinical consequences of “minimally involved” sentinel lymph nodes remain controversial. Herein, we present some of the complex and challenging pathological problems inherent in this evolving setting. Clearly, at least some of our current concepts regarding “minimally involved” sentinel lymph nodes need reappraisal.
Collapse
Affiliation(s)
- Michael Rivera
- Department of Pathology, New York Presbyterian Hospital-Weill Cornell Medical Center and Weill Medical College of Cornell University, New York, NY, USA
| | | | | | | | | |
Collapse
|
77
|
Singla T, Montoya F, Rivera M, Tajima S, Nakabayashi S, Parmananda P. Synchronization using environmental coupling in mercury beating heart oscillators. Chaos 2016; 26:063103. [PMID: 27368768 DOI: 10.1063/1.4953014] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
We report synchronization of Mercury Beating Heart (MBH) oscillators using the environmental coupling mechanism. This mechanism involves interaction of the oscillators with a common medium/environment such that the oscillators do not interact among themselves. In the present work, we chose a modified MBH system as the common environment. In the absence of coupling, this modified system does not exhibit self sustained oscillations. It was observed that, as a result of the coupling of the MBH oscillators with this common environment, the electrical and the mechanical activities of both the oscillators synchronized simultaneously. Experimental results indicate the emergence of both lag and the complete synchronization in the MBH oscillators. Simulations of the phase oscillators were carried out in order to better understand the experimental observations.
Collapse
Affiliation(s)
- Tanu Singla
- Department of Physics, Indian Institute of Technology Bombay, Powai, Mumbai 400 076, India
| | - Fernando Montoya
- Instituto de Biotecnología, UNAM, Avenida Universidad 2001, Colonia Chamilpa, Cuernavaca, Morelos, Mexico
| | - M Rivera
- Facultad de Ciencias, UAEM, Avenida Universidad 1001, Colonia Chamilpa, Cuernavaca, Morelos, Mexico
| | - Shunsuke Tajima
- Department of Chemistry, Faculty of Science, Saitama University, Saitama 338-8570, Japan
| | - Seiichiro Nakabayashi
- Department of Chemistry, Faculty of Science, Saitama University, Saitama 338-8570, Japan
| | - P Parmananda
- Department of Physics, Indian Institute of Technology Bombay, Powai, Mumbai 400 076, India
| |
Collapse
|
78
|
Chintakuntlawar AV, Shon W, Erickson-Johnson M, Bilodeau E, Jenkins SM, Davidson JA, Keeney MG, Rivera M, Price DL, Moore EJ, Olsen KD, Kasperbauer JL, Foote RL, Price KA, García JJ. High-grade transformation of acinic cell carcinoma: an inadequately treated entity? Oral Surg Oral Med Oral Pathol Oral Radiol 2016; 121:542-549.e1. [DOI: 10.1016/j.oooo.2016.01.011] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2015] [Revised: 01/12/2016] [Accepted: 01/13/2016] [Indexed: 10/22/2022]
|
79
|
Chintakuntlawar A, Shon W, Erickson-Johnson M, Bilodeau E, Jenkins S, Davidson J, Keeney M, Rivera M, Price D, Moore E, Olsen K, Kasperbauer J, Foote R, Price K, Garcia J. High-Grade Transformation of Acinic Cell Carcinoma: Potentially Underrecognized and Inadequately Treated. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2015.12.282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
80
|
Mullins N, Power RA, Fisher HL, Hanscombe KB, Euesden J, Iniesta R, Levinson DF, Weissman MM, Potash JB, Shi J, Uher R, Cohen-Woods S, Rivera M, Jones L, Jones I, Craddock N, Owen MJ, Korszun A, Craig IW, Farmer AE, McGuffin P, Breen G, Lewis CM. Polygenic interactions with environmental adversity in the aetiology of major depressive disorder. Psychol Med 2016; 46:759-770. [PMID: 26526099 PMCID: PMC4754832 DOI: 10.1017/s0033291715002172] [Citation(s) in RCA: 114] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/14/2015] [Revised: 09/22/2015] [Accepted: 09/22/2015] [Indexed: 12/30/2022]
Abstract
BACKGROUND Major depressive disorder (MDD) is a common and disabling condition with well-established heritability and environmental risk factors. Gene-environment interaction studies in MDD have typically investigated candidate genes, though the disorder is known to be highly polygenic. This study aims to test for interaction between polygenic risk and stressful life events (SLEs) or childhood trauma (CT) in the aetiology of MDD. METHOD The RADIANT UK sample consists of 1605 MDD cases and 1064 controls with SLE data, and a subset of 240 cases and 272 controls with CT data. Polygenic risk scores (PRS) were constructed using results from a mega-analysis on MDD by the Psychiatric Genomics Consortium. PRS and environmental factors were tested for association with case/control status and for interaction between them. RESULTS PRS significantly predicted depression, explaining 1.1% of variance in phenotype (p = 1.9 × 10(-6)). SLEs and CT were also associated with MDD status (p = 2.19 × 10(-4) and p = 5.12 × 10(-20), respectively). No interactions were found between PRS and SLEs. Significant PRSxCT interactions were found (p = 0.002), but showed an inverse association with MDD status, as cases who experienced more severe CT tended to have a lower PRS than other cases or controls. This relationship between PRS and CT was not observed in independent replication samples. CONCLUSIONS CT is a strong risk factor for MDD but may have greater effect in individuals with lower genetic liability for the disorder. Including environmental risk along with genetics is important in studying the aetiology of MDD and PRS provide a useful approach to investigating gene-environment interactions in complex traits.
Collapse
Affiliation(s)
- N. Mullins
- MRC Social, Genetic and Developmental Psychiatry
Centre, Institute of Psychiatry, Psychology &
Neuroscience, King's College London,
London, UK
| | - R. A. Power
- MRC Social, Genetic and Developmental Psychiatry
Centre, Institute of Psychiatry, Psychology &
Neuroscience, King's College London,
London, UK
| | - H. L. Fisher
- MRC Social, Genetic and Developmental Psychiatry
Centre, Institute of Psychiatry, Psychology &
Neuroscience, King's College London,
London, UK
| | - K. B. Hanscombe
- Division of Genetics and Molecular
Medicine, King's College London School of Medicine,
Guy's Hospital, London,
UK
| | - J. Euesden
- MRC Social, Genetic and Developmental Psychiatry
Centre, Institute of Psychiatry, Psychology &
Neuroscience, King's College London,
London, UK
| | - R. Iniesta
- MRC Social, Genetic and Developmental Psychiatry
Centre, Institute of Psychiatry, Psychology &
Neuroscience, King's College London,
London, UK
| | - D. F. Levinson
- Department of Psychiatry and Behavioral
Sciences, Stanford University, Stanford,
CA, USA
| | - M. M. Weissman
- Department of Psychiatry,
Columbia University and New York State Psychiatric Institute,
New York, NY, USA
| | - J. B. Potash
- Department of Psychiatry,
University of Iowa, Iowa City, IA,
USA
| | - J. Shi
- Division of Cancer Epidemiology and
Genetics, National Cancer Institute,
Bethesda, MD, USA
| | - R. Uher
- MRC Social, Genetic and Developmental Psychiatry
Centre, Institute of Psychiatry, Psychology &
Neuroscience, King's College London,
London, UK
- Department of Psychiatry,
Dalhousie University, Halifax,
Nova Scotia, Canada
| | - S. Cohen-Woods
- Discipline of Psychiatry,
School of Medicine, University of
Adelaide, Adelaide, South
Australia, Australia
| | - M. Rivera
- MRC Social, Genetic and Developmental Psychiatry
Centre, Institute of Psychiatry, Psychology &
Neuroscience, King's College London,
London, UK
- CIBERSAM-University of Granada and Instituto de
Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios
de Granada/Universidad de Granada, Granada,
Spain
| | - L. Jones
- Department of Psychiatry,
School of Clinical and Experimental Medicine,
University of Birmingham, Birmingham,
UK
| | - I. Jones
- MRC Centre for Neuropsychiatric Genetics and
Genomics, Neuroscience and Mental Health Research
Institute, Cardiff University,
Cardiff, UK
| | - N. Craddock
- MRC Centre for Neuropsychiatric Genetics and
Genomics, Neuroscience and Mental Health Research
Institute, Cardiff University,
Cardiff, UK
| | - M. J. Owen
- MRC Centre for Neuropsychiatric Genetics and
Genomics, Neuroscience and Mental Health Research
Institute, Cardiff University,
Cardiff, UK
| | - A. Korszun
- Barts and The London Medical School,
Queen Mary University of London, London,
UK
| | - I. W. Craig
- MRC Social, Genetic and Developmental Psychiatry
Centre, Institute of Psychiatry, Psychology &
Neuroscience, King's College London,
London, UK
| | - A. E. Farmer
- MRC Social, Genetic and Developmental Psychiatry
Centre, Institute of Psychiatry, Psychology &
Neuroscience, King's College London,
London, UK
| | - P. McGuffin
- MRC Social, Genetic and Developmental Psychiatry
Centre, Institute of Psychiatry, Psychology &
Neuroscience, King's College London,
London, UK
| | - G. Breen
- MRC Social, Genetic and Developmental Psychiatry
Centre, Institute of Psychiatry, Psychology &
Neuroscience, King's College London,
London, UK
- NIHR Biomedical Research Centre for Mental
Health, South London and Maudsley NHS Foundation Trust and Institute
of Psychiatry, Psychology & Neuroscience, King's College
London, London, UK
| | - C. M. Lewis
- MRC Social, Genetic and Developmental Psychiatry
Centre, Institute of Psychiatry, Psychology &
Neuroscience, King's College London,
London, UK
- Division of Genetics and Molecular
Medicine, King's College London School of Medicine,
Guy's Hospital, London,
UK
| |
Collapse
|
81
|
Abstract
Amyloid is a characteristic histologic feature in medullary thyroid carcinomas (MTC). We utilized a novel mass spectrometry-based proteomic analysis to determine if we could identify specific proteins associated with amyloid in MTC. We studied 9 MTC (1 multiple endocrine neoplasia type 2A, 1 familial MTC, and 7 sporadic). Laser microdissection was utilized to sample the amyloid which was then trypsin digested and evaluated by liquid chromatography electrospray tandem MS (LC-MS/MS) which identified the presence of amyloidogenic proteins in all cases of MTC. High levels of calcitonin were identified in all 9 cases of MTC. Secretogranin-1 was identified in 6 of 9 MTC. Calcitonin gene-related peptide was identified in 4 of 9 cases of MTC. LC-MS/MS proteomic analysis provides a rapid, highly specific, and sensitive method for identification of the specific type of amyloid in these endocrine tumors. This approach may allow classification of different forms of endocrine amyloid present in neuroendocrine tumors.
Collapse
Affiliation(s)
- Lori A Erickson
- Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55901, USA.
| | - Julie A Vrana
- Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55901, USA
| | - Jason Theis
- Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55901, USA
| | - Michael Rivera
- Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55901, USA
| | - Ricardo V Lloyd
- Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55901, USA
| | - Ellen McPhail
- Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55901, USA
| | - Jun Zhang
- Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55901, USA
| |
Collapse
|
82
|
Gómez V, Orosa A, Rivera M, Diez-Nicolás V, Hevia V, Alvarez S, Carracedo D, Ramos E, Burgos FJ. Resistance index determination in the pre and post kidney transplantation time points in graft dysfunction diagnosis. Transplant Proc 2015; 47:34-7. [PMID: 25645764 DOI: 10.1016/j.transproceed.2014.11.027] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
BACKGROUND Donor shortage necessitates the development of tools capable of objectively assessing kidney graft quality from expanded criteria donors and kidneys donated after cardiac death. The deteriorating donor profile is leading to a shift from cold storage toward machine perfusion preservation. Several authors found that renal resistance (RR) at the end of machine perfusion was an independent risk factor for the development of delayed graft function (DGF). In contrast, Doppler ultrasonography in the posttransplant period reveals renal hemodynamics and is useful in diagnosing renal allograft dysfunction. We sought to determine concordance between RR and the resistance index (RI) and their diagnostic value in the assessment of graft viability. METHODS RR was determined at the end of perfusion during hypothermic machine preservation and RI was measured by Doppler ultrasonography in the early posttransplant period. Agreement between these 2 measures was established by means of the intraclass correlation coefficient (ICC). Diagnostic validity for RR and RI was determined by sensitivity, specificity and positive and negative predictive values. RESULTS The ICC was 0.135, which indicates a slight agreement. RR and RI had limited value in the prediction of DGF for a specific kidney as reflected by a c-statistic of 0.58 and 0.66, respectively. CONCLUSIONS There is no agreement between the RR and RI, which may be owing to the different conditions under which measurements are made. The poor predictive power of RR for DGF indicates that kidneys should not be discarded based on RR criteria alone.
Collapse
Affiliation(s)
- V Gómez
- Department of Urology, Ramón y Cajal University Hospital, Alcalá University, Madrid, Spain.
| | - A Orosa
- Department of Urology, Ramón y Cajal University Hospital, Alcalá University, Madrid, Spain
| | - M Rivera
- Department of Nephrology, Ramón y Cajal University Hospital, Alcalá University, Madrid, Spain
| | - V Diez-Nicolás
- Department of Urology, Ramón y Cajal University Hospital, Alcalá University, Madrid, Spain
| | - V Hevia
- Department of Urology, Ramón y Cajal University Hospital, Alcalá University, Madrid, Spain
| | - S Alvarez
- Department of Urology, Ramón y Cajal University Hospital, Alcalá University, Madrid, Spain
| | - D Carracedo
- Department of Urology, Ramón y Cajal University Hospital, Alcalá University, Madrid, Spain
| | - E Ramos
- Cellular Response to Ischemia Group, Ramón y Cajal University Hospital, Alcalá University, Madrid, Spain
| | - F J Burgos
- Department of Urology, Ramón y Cajal University Hospital, Alcalá University, Madrid, Spain
| |
Collapse
|
83
|
Giannini C, Spengel KC, Abell Aleff PC, Rivera M, Wald JT. 24-Year-Old Woman with Recent Onset Back Pain. Brain Pathol 2015; 25:786-7. [PMID: 26526948 DOI: 10.1111/bpa.12324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Affiliation(s)
- Caterina Giannini
- Department of Anatomic Pathology, Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN
| | | | - Patrice C Abell Aleff
- Department of Electron Microscopy, Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN
| | - Michael Rivera
- Department of Anatomic Pathology, Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN
| | - John T Wald
- Department of Neuroradiology, Diagnostic Radiology, Mayo Clinic, Rochester, MN
| |
Collapse
|
84
|
Medina L, Acosta-Pérez E, Velez C, Martínez G, Rivera M, Sardiñas L, Pattatucci A. Training and capacity building evaluation: Maximizing resources and results with Success Case Method. Eval Program Plann 2015; 52:126-132. [PMID: 26036611 PMCID: PMC4509803 DOI: 10.1016/j.evalprogplan.2015.03.008] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/26/2013] [Revised: 03/19/2015] [Accepted: 03/24/2015] [Indexed: 06/04/2023]
Abstract
This article describes the use of Success Case Method (Brinkerhoff, 2003) to evaluate health promotion and public health training programs. The goal of the Office Community Research and Engagement (OCRE) of the Puerto Rico Clinical and Translational Research Consortium (PRCTRC) is to establish a stable and sustainable translational research capacity. Early efforts toward achieving this goal included sponsoring two independent research training programs. A description of the implementation of the five step Success Case Method is presented. Results reveal that SCM would deem both trainings as highly successful, based upon the overall impact of a low number of success cases. However, a traditional summative evaluation would consider this disappointing. Strengths of SCM are discussed. It was concluded that the Success Case Method is a useful and valuable evaluative method for measuring the success of health promotion and public health training initiatives and provides sufficient information for decision-making processes.
Collapse
Affiliation(s)
- L Medina
- Puerto Rico Clinical and Translational Research Consortium, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico; Center for Evaluation and Sociomedical Research, Graduate School of Public Health, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico; UPR-MDACC Partnership for Excellence in Cancer Research, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico
| | - E Acosta-Pérez
- Puerto Rico Clinical and Translational Research Consortium, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico; Center for Evaluation and Sociomedical Research, Graduate School of Public Health, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico.
| | - C Velez
- UPR-MDACC Partnership for Excellence in Cancer Research, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico
| | - G Martínez
- Puerto Rico Clinical and Translational Research Consortium, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico
| | - M Rivera
- Puerto Rico Clinical and Translational Research Consortium, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico; Center for Evaluation and Sociomedical Research, Graduate School of Public Health, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico; UPR-MDACC Partnership for Excellence in Cancer Research, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico
| | - L Sardiñas
- Puerto Rico Clinical and Translational Research Consortium, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico; Center for Evaluation and Sociomedical Research, Graduate School of Public Health, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico
| | - A Pattatucci
- Puerto Rico Clinical and Translational Research Consortium, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico; Center for Evaluation and Sociomedical Research, Graduate School of Public Health, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico; UPR-MDACC Partnership for Excellence in Cancer Research, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico
| |
Collapse
|
85
|
|
86
|
Crispino P, Pica R, Unim H, Rivera M, Cassieri C, Zippi M, Paoluzi P. Efficacy of mesalazine or beclomethasone dipropionate enema or their combination in patients with distal active ulcerative colitis. Eur Rev Med Pharmacol Sci 2015; 19:2830-7. [PMID: 26241537 DOI: pmid/26241537] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
OBJECTIVE Mesalazine or Beclomethasone dipropionate (BDP) enema have been shown effective in treatment of distal active ulcerative colitis (UC). This study was aimed to determine whether the combination of topical mesalazine and BDP is superior to topical mesalazine or BDP used alone in patients with distal active UC. PATIENTS AND METHODS: One-hundred and twenty patients with clinical, endoscopic and histological diagnosis of distal active UC were randomly assigned to a regimen with mesalazine tablets 2.4 g/day associated to either mesalazine enema 4 g/day (group A, n=40), BDP 3 mg/60 ml every day (group B, n=40) or the combination treatment with the two compounds in a single administration (group C, n=40) for eight weeks. After four weeks of treatment all patients underwent clinical controls but only 109 patients returned back for clinical, endoscopic and histological controls at the end of the treatment period. RESULTS After eight weeks, complete remission rates were of 52%, 47% and 65% respectively, in group A, B and C. From baseline to 4 and 8 weeks the CAI score decreased significantly in all the three groups (p < 0.0001). CONCLUSIONS All the three combinations achieved equivalent results in terms of symptoms in inducing symptoms relief and mucosa healing in distally active UC.
Collapse
Affiliation(s)
- P Crispino
- Gastroenterology Unit, Department of Clinical Sciences, University "Sapienza" of Rome, Rome, Italy.
| | | | | | | | | | | | | |
Collapse
|
87
|
Ferentinos P, Koukounari A, Power R, Rivera M, Uher R, Craddock N, Owen MJ, Korszun A, Jones L, Jones I, Gill M, Rice JP, Ising M, Maier W, Mors O, Rietschel M, Preisig M, Binder EB, Aitchison KJ, Mendlewicz J, Souery D, Hauser J, Henigsberg N, Breen G, Craig IW, Farmer AE, Müller-Myhsok B, McGuffin P, Lewis CM. Familiality and SNP heritability of age at onset and episodicity in major depressive disorder. Psychol Med 2015; 45:2215-2225. [PMID: 25698070 PMCID: PMC4462162 DOI: 10.1017/s0033291715000215] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/25/2014] [Revised: 01/11/2015] [Accepted: 01/22/2015] [Indexed: 11/24/2022]
Abstract
BACKGROUND Strategies to dissect phenotypic and genetic heterogeneity of major depressive disorder (MDD) have mainly relied on subphenotypes, such as age at onset (AAO) and recurrence/episodicity. Yet, evidence on whether these subphenotypes are familial or heritable is scarce. The aims of this study are to investigate the familiality of AAO and episode frequency in MDD and to assess the proportion of their variance explained by common single nucleotide polymorphisms (SNP heritability). METHOD For investigating familiality, we used 691 families with 2-5 full siblings with recurrent MDD from the DeNt study. We fitted (square root) AAO and episode count in a linear and a negative binomial mixed model, respectively, with family as random effect and adjusting for sex, age and center. The strength of familiality was assessed with intraclass correlation coefficients (ICC). For estimating SNP heritabilities, we used 3468 unrelated MDD cases from the RADIANT and GSK Munich studies. After similarly adjusting for covariates, derived residuals were used with the GREML method in GCTA (genome-wide complex trait analysis) software. RESULTS Significant familial clustering was found for both AAO (ICC = 0.28) and episodicity (ICC = 0.07). We calculated from respective ICC estimates the maximal additive heritability of AAO (0.56) and episodicity (0.15). SNP heritability of AAO was 0.17 (p = 0.04); analysis was underpowered for calculating SNP heritability of episodicity. CONCLUSIONS AAO and episodicity aggregate in families to a moderate and small degree, respectively. AAO is under stronger additive genetic control than episodicity. Larger samples are needed to calculate the SNP heritability of episodicity. The described statistical framework could be useful in future analyses.
Collapse
Affiliation(s)
- P. Ferentinos
- MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- 2nd Department of Psychiatry, Attikon General Hospital, University of Athens, Athens, Greece
| | - A. Koukounari
- Department of Biostatistics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - R. Power
- MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - M. Rivera
- MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, University of Granada, Spain
| | - R. Uher
- MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- Dalhousie University Department of Psychiatry, Halifax, Nova Scotia, Canada
| | - N. Craddock
- MRC Centre for Neuropsychiatric Genetics and Genomics, Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, UK
| | - M. J. Owen
- MRC Centre for Neuropsychiatric Genetics and Genomics, Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, UK
| | - A. Korszun
- Barts and The London Medical School, Queen Mary University of London, London, UK
| | - L. Jones
- Department of Psychiatry, University of Birmingham, Birmingham, UK
| | - I. Jones
- MRC Centre for Neuropsychiatric Genetics and Genomics, Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, UK
| | - M. Gill
- Department of Psychiatry, Trinity Centre for Health Science, Dublin, Ireland
| | - J. P. Rice
- Department of Psychiatry, Washington University, St. Louis, Missouri, USA
| | - M. Ising
- Max Planck Institute of Psychiatry, Munich, Germany
| | - W. Maier
- Department of Psychiatry, University of Bonn & German Center of Neurodegenerative Diseases (DZNE), Bonn, Germany
| | - O. Mors
- Centre for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark
| | - M. Rietschel
- Division of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany
| | - M. Preisig
- University Hospital Center and University of Lausanne, Lausanne, Switzerland
| | - E. B. Binder
- Max Planck Institute of Psychiatry, Munich, Germany
| | - K. J. Aitchison
- Departments of Psychiatry and Medical Genetics, University of Alberta, Edmonton, Alberta, Canada
| | - J. Mendlewicz
- Department of Psychiatry, Free University of Brussels, Brussels, Belgium
| | - D. Souery
- Centre Européen de Psychologie Médicale PSY-PLURIEL, Bruxelles, Belgium
| | - J. Hauser
- Department of Genetics in Psychiatry, Poznan University of Medical Sciences, Poznan, Poland
| | - N. Henigsberg
- Department of Psychiatry, University of Zagreb, Zagreb, Croatia
| | - G. Breen
- MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- NIHR Biomedical Research Centre for Mental Health, South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - I. W. Craig
- MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - A. E. Farmer
- MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | | | - P. McGuffin
- MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - C. M. Lewis
- MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- Division of Genetics and Molecular Medicine, King's College London, London, UK
| |
Collapse
|
88
|
Verma DK, Singh H, Parmananda P, Contractor AQ, Rivera M. Kuramoto transition in an ensemble of mercury beating heart systems. Chaos 2015; 25:064609. [PMID: 26117134 DOI: 10.1063/1.4921717] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
We have studied, experimentally, the collective behavior of the electrically coupled autonomous Mercury Beating Heart (MBH) systems exhibiting the breathing mode, by varying both the coupling strength and the population size (from N = 3 to N = 16). For a fixed N, the electrical and the mechanical activities of the MBH systems achieve complete synchronization at different coupling strengths. The electrical activity of each MBH system is measured by the corresponding electrode potential (Ei = Vi). Additionally, the mechanical activity of each MBH oscillator is visually observed (snapshots and video clips). Subsequently, this activity is quantified by calculating the temporal variation in the area (Ai) of the Hg drop. As a result, the synchronization of the electrical (Ei = Vi) and the mechanical (Ai) activities can be measured. The extent of synchronization was quantified by employing the order parameter (r). Our experimental results are found to be in agreement with the Kuramoto theory.
Collapse
Affiliation(s)
- Dinesh Kumar Verma
- Department of Physics, Indian Institute of Technology, Bombay, Powai, Mumbai 400076, India
| | - Harpartap Singh
- Department of Physics, Indian Institute of Technology, Bombay, Powai, Mumbai 400076, India
| | - P Parmananda
- Department of Physics, Indian Institute of Technology, Bombay, Powai, Mumbai 400076, India
| | - A Q Contractor
- Department of Chemistry, Indian Institute of Technology, Bombay, Powai, Mumbai 400076, India
| | - M Rivera
- Centro de Investigación en Ciencias, UAEM, Avenida Universidad 1001, Colonia Chamilpa, Cuernavaca, Morelos, Mexico
| |
Collapse
|
89
|
Wreesmann VB, Nixon IJ, Rivera M, Katabi N, Palmer F, Ganly I, Shaha AR, Tuttle RM, Shah JP, Patel SG, Ghossein RA. Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma. Thyroid 2015; 25:503-8. [PMID: 25748079 PMCID: PMC4968276 DOI: 10.1089/thy.2015.0052] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
BACKGROUND Vascular invasion (VI) is an important predictor of distant metastasis and possible radioactive iodine (RAI) benefit in follicular, Hürthle cell, and poorly differentiated thyroid carcinomas, but its role in well-differentiated papillary thyroid cancer (WDTC) remains unclear. METHODS Archived pathological material of all differentiated thyroid carcinoma patients undergoing primary surgical treatment at Memorial Sloan-Kettering Cancer Center between 1986 and 2003 was reviewed by two dedicated thyroid pathologists. Only WDTCs were included in the present study. Standard statistical methods were used to assess the relationship between VI and outcomes of interest, including 10-year disease-specific survival (DSS), regional recurrence-free survival (RRFS), and distant recurrence-free survival (DRFS). RESULTS VI was present in 47 of 698 WDTC (6.7%). VI was significantly associated with tumor size >4.0 cm, extrathyroidal extension, distant metastasis, and RAI treatment. On univariate analysis, VI was predictive of decreased 10-year DRFS, but not DSS or RRFS. On multivariate analysis, VI was not an independent predictor of DRFS. Univariate survival analysis of 422 RAI-naïve WDTC showed that both size >4 cm and VI were predictors of outcome, but only size remained independently predictive on multivariate analysis. CONCLUSION The presence of VI is not an independent predictor of outcome in WDTC.
Collapse
Affiliation(s)
- Volkert B Wreesmann
- 1 Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center , New York, New York
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
90
|
Portoles J, Janeiro D, Garcia-Menendez E, Tornero F, Lopez-Sanchez P, Fernández JN, Castellano I, Fernández-Perpen A, Rivera M, Selgas R. FP595ON THE VIEW OF CLINICAL OUTCOMES, SHOULD WE OFFER PD FOR ELDERLY PATIENTS? Nephrol Dial Transplant 2015. [DOI: 10.1093/ndt/gfv180.47] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
91
|
Rivera M, Gonzalo A, Urdanibia JF, Gobernado J, Antolín JN, Lucas MF, Ortuño J. Magnetic resonance angiography and intracranial aneurysms in polycystic kidney disease. A preliminary study. Contrib Nephrol 2015; 115:167-70. [PMID: 8585909 DOI: 10.1159/000424418] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Affiliation(s)
- M Rivera
- Nephrology Service, Hospital Ramón y Cajal, Madrid, Spain
| | | | | | | | | | | | | |
Collapse
|
92
|
Gonzalo A, Gallego A, Rivera M, Orte L, Ortuño J. Least square regression analysis of arterial pressure estimators contributing to early renal failure in ADPKD. Contrib Nephrol 2015; 115:171-6. [PMID: 8585910 DOI: 10.1159/000424419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Affiliation(s)
- A Gonzalo
- Servicio de Nefrologia, Hospital Ramón y Cajal y, Madrid, Spain
| | | | | | | | | |
Collapse
|
93
|
Rivera M, Marcén R, Maciá A, Lucas MF, Quereda C, Gonzalo A, Orofino L, Ortuño J. Renal transplantation in polycystic kidney disease. Contrib Nephrol 2015; 115:144-9. [PMID: 8585903 DOI: 10.1159/000424413] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Affiliation(s)
- M Rivera
- Hospital Ramón y Cajal, Nephrology Service, Madrid, Spain
| | | | | | | | | | | | | | | |
Collapse
|
94
|
Kasaian K, Chindris AM, Wiseman SM, Mungall KL, Zeng T, Tse K, Schein JE, Rivera M, Necela BM, Kachergus JM, Casler JD, Mungall AJ, Moore RA, Marra MA, Copland JA, Thompson EA, Smallridge RC, Jones SJM. MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinoma. J Clin Endocrinol Metab 2015; 100:E611-5. [PMID: 25625803 PMCID: PMC4399284 DOI: 10.1210/jc.2014-3622] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
CONTEXT AND OBJECTIVE Oncocytic thyroid carcinoma, also known as Hürthle cell thyroid carcinoma, accounts for only a small percentage of all thyroid cancers. However, this malignancy often presents at an advanced stage and poses unique challenges to patients and clinicians. Surgical resection of the tumor accompanied in some cases by radioactive iodine treatment, radiation, and chemotherapy are the established modes of therapy. Knowledge of the perturbed oncogenic pathways can provide better understanding of the mechanism of disease and thus opportunities for more effective clinical management. DESIGN AND PATIENTS Initially, two oncocytic thyroid carcinomas and their matched normal tissues were profiled using whole genome sequencing. Subsequently, 72 oncocytic thyroid carcinomas, one cell line, and five Hürthle cell adenomas were examined by targeted sequencing for the presence of mutations in the multiple endocrine neoplasia I (MEN1) gene. RESULTS Here we report the identification of MEN1 loss-of-function mutations in 4% of patients diagnosed with oncocytic thyroid carcinoma. Whole genome sequence data also revealed large regions of copy number variation encompassing nearly the entire genomes of these tumors. CONCLUSION Menin, a ubiquitously expressed nuclear protein, is a well-characterized tumor suppressor whose loss is the cause of MEN1 syndrome. Menin is involved in several major cellular pathways such as regulation of transcription, control of cell cycle, apoptosis, and DNA damage repair pathways. Mutations of this gene in a subset of Hürthle cell tumors point to a potential role for this protein and its associated pathways in thyroid tumorigenesis.
Collapse
Affiliation(s)
- Katayoon Kasaian
- Canada's Michael Smith Genome Sciences Centre (K.K., K.L.M., T.Z., K.T., J.E.S., A.J.M., R.A.M., M.A.M., S.J.M.J.), BC Cancer Agency, Vancouver, V5Z 4S6 Canada; Department of Otorhinolaryngology-Head and Neck Surgery (A.-M.C., J.D.C.), Mayo Clinic, Jacksonville, Florida 32224; Department of Surgery (S.M.W.), St. Paul's Hospital and University of British Columbia, Vancouver, V6Z 1Y6 Canada; Department of Laboratory Medicine and Pathology (M.R.), Mayo Clinic, Rochester, Minnesota 55905; Department of Cancer Biology (B.M.N., J.M.K., J.A.C., E.A.T., R.C.S.), Mayo Clinic, Jacksonville, Florida 32224; Department of Medical Genetics (M.A.M., S.J.M.J.), University of British Columbia, Vancouver, V6T 1Z4 Canada; Department of Medicine, Division of Endocrinology and Metabolism (R.C.S.), Mayo Clinic, Jacksonville, Florida 32224; and Department of Molecular Biology and Biochemistry (S.J.M.J.), Simon Fraser University, Burnaby, V5A 1S6 Canada
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
95
|
Berenguer R, Gutierrez-Perez M, Rivera M, Nuñez-Quintanilla A, De la Vara V, Sabater S, Villas-Sanchez M. EP-1361: Comparison of 4 multichannel radiochromic film dosimetry procedures. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)41353-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
96
|
Kaiser C, Klestinski K, Tsuji J, Sabatino T, Yorke N, Johnson R, Arnhold K, Otten J, Ahn P, Cephus K, Dittlof A, Ortega L, Foster H, Hernandez M, Rivera M, Strom D, Strom J, Yang N, Dittrich N, Waas M. Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibition Yields Promising Future Implications. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.lb61] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Carl Kaiser
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - Keith Klestinski
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - J Tsuji
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - T Sabatino
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - N Yorke
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - R Johnson
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - K Arnhold
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - J Otten
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - P Ahn
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - K Cephus
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - A Dittlof
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - L Ortega
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - H Foster
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - M Hernandez
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - M Rivera
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - D Strom
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - J Strom
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - N Yang
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - N Dittrich
- Science Marquette University High SchoolMilwaukeeWIUnited States
| | - Matthew Waas
- BiochemistryMedical College of WisconsinMilwaukeeWIUnited States
| |
Collapse
|
97
|
Crespo MJ, Casiano H, Morales M, Torres H, Torres‐Grajales M, Hernandez C, Rivera M, Cruz N, Quidgley J. Deleterious Effects of Low and Medium Doses of Clonidine on Left Ventricular Function in Diabetic Rats. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.1043.5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- M J. Crespo
- PhysiologyUPR‐School of MedicineSan JuanPuerto Rico
- AnesthesiologyUPR‐School of MedicineSan JuanPuerto Rico
| | - H Casiano
- AnesthesiologyUPR‐School of MedicineSan JuanPuerto Rico
| | - M Morales
- AnesthesiologyUPR‐School of MedicineSan JuanPuerto Rico
| | - H Torres
- AnesthesiologyUPR‐School of MedicineSan JuanPuerto Rico
| | | | - C Hernandez
- AnesthesiologyUPR‐School of MedicineSan JuanPuerto Rico
| | - M Rivera
- AnesthesiologyUPR‐School of MedicineSan JuanPuerto Rico
| | - N Cruz
- PhysiologyUPR‐School of MedicineSan JuanPuerto Rico
| | - J Quidgley
- PhysiologyUPR‐School of MedicineSan JuanPuerto Rico
| |
Collapse
|
98
|
Núñez Quintanilla A, Berenguer R, Rivera M, De la Vara V, Gutiérrez-Pérez M, Sabater S, Villas V. PO-0924: PTV margin calculation using an IGRT system for prostate treatments. Pelvic nodes margin assessment. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40916-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
99
|
Rivera M, Locke A, Corre T, Czamara D, Wolf C, Ching-Lopez A, Milaneschi Y, Kloiber S, Boomsma D, Müller-Myhsok B, Penninx B, Preisig M, Farmer A, Lewis C, Breen G, McGuffin P. Genetic Relationship Between Depression and Body Mass Index. Eur Psychiatry 2015. [DOI: 10.1016/s0924-9338(15)30560-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
100
|
Mendoza-Huizar LH, Garrido-Márquez D, Rios-Reyes CH, Rivera M, García-Sánchez E, Galán-Vidal C. A Kinetic and AFM Study of the Electrodeposition of Palladium Nanoclusters onto Highly Oriented Pyrolytic Graphite (HOPG). J CLUST SCI 2015. [DOI: 10.1007/s10876-014-0837-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|